Global Health Summit 2026
)
The Design Museum, London, United Kingdom, 23 March - 24 March 2026
This is our first annual Health Summit and will bring together key opinion leaders from around the world to discuss the integration of multi-dimensional genomics into precision healthcare.
The Summit will explore how genomics and multi-omics can transform global health outcomes through representation, innovation, and collaboration. Together, we’ll discuss how science, technology, and policy can align to create lasting impact across communities worldwide.
Confirmed speakers:
- Tobias Rausch, European Molecular Biology Laboratory (EMBL)
- Nicola Mulder, University of Cape Town
- Tjitske Kleefstra, Erasmus MC
- Nickhill Bhakta, St Jude Children’s Research Hospital
- Rory Collins, UK Biobank
- Ewan Birney, EMBL
- Nathalie Kingston, National Institute for Health and Care Research (NIHR) BioResource and Cambridge University
- Danny Miller, University of Washington
Please note that this is an in-person event by invitation only. To enquire about attendance please contact events@nanoporetech.com.
Why join us?
- Build long-term stakeholder networks to ensure alignment with national and global health innovation missions
- Empower the local communities to further close the gaps in representation and diversity to achieve the goals of inclusive precision health globally
- Help accelerate innovation and clinical integration of research tools
- Gain policy insight to inform implementation, reimbursement, and funding decisions
- Collaborate with global partners
- Help shape shared roadmaps and participate in ongoing annual engagement
- Enjoy networking with peers
Agenda
9:00 am - 5:45 pm GMT | Agenda (subject to change) | Speaker |
|---|---|---|
8:30 am - 9:00 am | Registration/refreshments | |
9:00 am - 9:15 am | Welcome from Oxford Nanopore Technologies | Oxford Nanopore Technologies |
9:15 am - 9:45 am | Keynote speaker | details to follow |
9:45 am - 11:05 am | Session One - Empowering local populations, globally | |
9:45 am - 10:00 am | details to follow | Nicola Mulder, University of Cape Town |
10:00 am - 10:15 am | details to follow | Tobias Rausch, European Molecular Biology Laboratory (EMBL) |
10:15 am - 10:30 am | details to follow | details to follow |
10:30 am - 11:05 am | Panel discussion - Current state of population study across the world | André G. Uitterlinden, Erasmus MC, Catalina Lopez Correa, Global Gene, Canada, Leandro Machado Colli, University of São Paulo |
11:05 am - 11:55 am | Networking Break | |
12:00 pm - 1:00 pm | Session Two - Multiomics to tackle healthcare challenges (complex diseases, cancer and rare) | |
12:00 pm - 12:15 pm | details to follow | details to follow |
12:15 pm - 12:30 pm | details to follow | Ewan Birney, EMBL |
12:30 pm - 1:00 pm | Panel discussion - At scale multiomic translational for future clinical implementation | Nathalie Kingston, NIHR / Cambridge Uni, Rory Collins, UK Biobank |
1:00 pm - 2:20 pm | Networking Lunch | |
2:20 pm - 3:40 pm | Session 3 – evidence of impact (increase of diagnostic yield) | |
2:20 pm - 2:35 pm | details to follow | Tjitske Kleefstra, Erasmus MC |
2:35 pm - 2:50 pm | details to follow | Danny Miller, University of Washington |
2:50 pm - 3:05 pm | details to follow | Nickhill Bhakta, St Jude Children's Research Hospital |
3:05 pm - 3:35 pm | Panel discussion - Increasing Diagnostic yield in RD | Matt Brown, Genomics England, Olaf Riess, Institute of Medical Genetics and Applied Genomics, Marilyn Li, The Children's Hospital of Philadelphia |
3:35 pm - 4:10 pm | Keynote speaker | |
4:10 pm - 5:00 pm | Networking break | |
5:00 pm - 5:45 pm | Next steps and closing remarks | Oxford Nanopore Technologies hosted |
5:45 pm onwards | Networking drinks reception |
